<SEC-DOCUMENT>0001213900-20-027951-index.html : 20200923
<SEC-HEADER>0001213900-20-027951.hdr.sgml : 20200923
<ACCEPTANCE-DATETIME>20200923090840
ACCESSION NUMBER:		0001213900-20-027951
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	20200921
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200923
DATE AS OF CHANGE:		20200923

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001359931
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				204580525
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36694
		FILM NUMBER:		201191059

	BUSINESS ADDRESS:	
		STREET 1:		1 LITTLE WEST 12TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014
		BUSINESS PHONE:		646-844-0337

	MAIL ADDRESS:	
		STREET 1:		1 LITTLE WEST 12TH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ArTara Therapeutics, Inc.
		DATE OF NAME CHANGE:	20200110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROTEON THERAPEUTICS INC
		DATE OF NAME CHANGE:	20060420
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea127215-8k_protarathera.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea127215-8k_protarathera.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea127215ex1-1_protara.htm
<DESCRIPTION>UNDERWRITING AGREEMENT RELATED TO THE COMMON OFFERING, DATED SEPTEMBER 22, 2020, AMONG PROTARA THERAPEUTICS, INC., COWEN AND COMPANY, LLC AND GUGGENHEIM SECURITIES, LLC
<TEXT>
Document 2 - file: ea127215ex1-1_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>3
<FILENAME>ea127215ex1-2_protara.htm
<DESCRIPTION>UNDERWRITING AGREEMENT RELATED TO THE PREFERRED OFFERING, DATED SEPTEMBER 22, 2020, AMONG PROTARA THERAPEUTICS, INC., COWEN AND COMPANY, LLC AND GUGGENHEIM SECURITIES, LLC
<TEXT>
Document 3 - file: ea127215ex1-2_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>4
<FILENAME>ea127215ex3-1_protara.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE SERIES 1 PREFERRED STOCK OF THE COMPANY
<TEXT>
Document 4 - file: ea127215ex3-1_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>5
<FILENAME>ea127215ex5-1_protara.htm
<DESCRIPTION>OPINION OF COOLEY LLP
<TEXT>
Document 5 - file: ea127215ex5-1_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ea127215ex99-1_protara.htm
<DESCRIPTION>PRESS RELEASE, DATED SEPTEMBER 21, 2020
<TEXT>
Document 6 - file: ea127215ex99-1_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>ea127215ex99-2_protara.htm
<DESCRIPTION>PRESS RELEASE, DATED SEPTEMBER 22, 2020
<TEXT>
Document 7 - file: ea127215ex99-2_protara.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 8 - file: ex5-1_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 9 - file: image_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>